Yahoo · Sep 8, 2026
GRFS or SDZNY: Which Is the Better Value Stock Right Now?
GRFS vs. SDZNY: Which Stock Is the Better Value Option?
NYSE · GRFS
Grifols, S.A.
Healthcare · Drug Manufacturers - General
$7.36
Up+$0.04 (+0.54%)
Updated Sep 16, 2026, 11:30 PM
SID Score
4.5/10
Composite research score
Smart Money
56/100
Neutral
- Market cap
- 7.74B
- P/E ratio
- 24.94
- Dividend yield
- 2.35%
- 52-week range
- $6.96 – $9.77
- Volume
- 590.63K
- Avg. volume
- 623.71K
Price performance
GRFS price history
1M range · 20 trading sessions · Daily adjusted prices
GRFS closed at $7.36 after 20 trading sessions, down 5.03% for the selected period.
- Last close
- $7.36
- Period change
- -5.03%
- Period low
- $7.36
- Period high
- $8.25
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $7.40 | $7.4692 | $7.34 | $7.36 | 590.63K |
| Sep 14, 2026 | $7.59 | $7.60 | $7.46 | $7.48 | 294.65K |
| Sep 11, 2026 | $7.67 | $7.72 | $7.55 | $7.55 | 513.35K |
| Sep 10, 2026 | $7.73 | $7.74 | $7.64 | $7.65 | 302.56K |
| Sep 9, 2026 | $7.77 | $7.89 | $7.71 | $7.82 | 703.34K |
| Sep 8, 2026 | $7.78 | $7.83 | $7.74 | $7.75 | 298.39K |
| Sep 4, 2026 | $7.82 | $7.84 | $7.77 | $7.80 | 157.91K |
| Sep 3, 2026 | $7.90 | $7.99 | $7.81 | $7.88 | 513.4K |
| Sep 2, 2026 | $7.71 | $7.8485 | $7.70 | $7.83 | 261.7K |
| Sep 1, 2026 | $7.74 | $7.89 | $7.70 | $7.73 | 284.25K |
| Aug 31, 2026 | $7.71 | $7.7585 | $7.65 | $7.72 | 623.98K |
| Aug 28, 2026 | $7.83 | $7.885 | $7.68 | $7.69 | 322.33K |
| Aug 27, 2026 | $7.88 | $7.95 | $7.805 | $7.82 | 545.32K |
| Aug 26, 2026 | $8.09 | $8.09 | $7.89 | $7.90 | 465.3K |
| Aug 25, 2026 | $8.03 | $8.09 | $7.99 | $8.09 | 375.06K |
| Aug 24, 2026 | $8.00 | $8.03 | $7.94 | $7.99 | 227.29K |
| Aug 21, 2026 | $8.03 | $8.118 | $7.98 | $8.00 | 218.38K |
| Aug 20, 2026 | $8.19 | $8.20 | $7.97 | $7.99 | 293.62K |
| Aug 19, 2026 | $7.81 | $8.38 | $7.81 | $8.25 | 926.39K |
| Aug 18, 2026 | $7.68 | $7.83 | $7.68 | $7.75 | 274.04K |
Latest GRFS news
The latest Smart Investors Daily articles mentioning GRFS.
Stock researchCompany · Overview
GRFS research
Overview
Company profile and research snapshot.
Company profile
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 30, 2026 | ALANTRA EQUITIES | Strong Buy | — |
| Jun 29, 2026 | BANCO SANTANDER | Outperform | — |
| Jun 26, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Jun 18, 2026 | BESTINVER SECURITIES | Buy | — |
| Jun 9, 2026 | CAIXABANK BPI | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 1, 2026
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
European equities traded in the US as American depositary receipts were trending slightly higher lat
Yahoo · Aug 19, 2026
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
European equities traded in the US as American depositary receipts were tracking higher late Wednesd
Yahoo · Aug 5, 2026
European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading
European equities traded in the US as American depositary receipts were edging higher late Wednesday
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
